Patent Classification

Treatment, Canker Sores

1. Method for retarding and ameliorating fever blisters and canker sores

Treatment, Cardiovascular/Heart Related Disorders

1. Cardiac targeted delivery of cells
    
2. Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
    
3. Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
    
4. Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
    
5. EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease
    
6. Des-methyl-tocopherol therapy for restenosis prevention
    
7. Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
    
8. Treatment of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart
    
9. Cellular therapy to heal vascular tissue
    
10. Diphtheria toxin variant
     
11. Therapeutic use of ADPase enhanced apyrases
     
12. Method for inhibiting a microvascular complication by administering IL-6
     
13. Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof
     
14. IL1RL-1 as a cardiovascular disease marker and therapeutic target
     
15. Gas-containing liposomes
     
16. Reverse vitamin K effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets
     
17. Medicinal compositions for preventing or treating viral myocarditis
     
18. Methods of treating vasodilatory shock
     
19. Method for preventing or treating cardiac hypertrophy
     
20. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
     
21. Drug for preventing or treating heart diseases comprising CD9 gene
     
22. Cardiovascular protection using anti-aldosteronic progestins
     
23. Preparation for the prophylaxis of restenosis
     
24. Method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
     
25. Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
     
26. Cardiac muscle function and manipulation
     
27. Use of PPAR agonists for the treatment of congestive heart failure
     
28. Treatment of cardiac power failure
     
29. Diphtheria toxin variant
     
30. Hirulog-like peptide and gene therapy
     
31. Aligned scaffolds for improved myocardial regeneration
     
32. Compositions and methods for promoting myocardial and peripheral angiogenesis
     
33. Antibodies to human vascular endothelial growth factor 2 and methods of using the same
     
34. Method for differentiating primate embryonic stem cell into vascular cell
     
35. Ace inhibitory peptides from plant materials
     
36. Method to induce neovascular formation and tissue regeneration
     
37. Method of preparing bio-identical hormones
     
38. Drug-eluting intravascular prostheses and methods of use
     
39. Preparation for the prevention and/or treatment of vascular disorders
     
40. Specific antibodies for diagnosing heart failure
     
41. Use of a phosphate adsorbent to combat vascular diseases
     
42. Methods and compositions for the repair and/or regeneration of damaged myocardium
     
43. Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP II
     
44. Method of producing cardiomyocytes from mesenchymal stem cells
     
45. Melusin a muscle specific protein, as a drug target for prevention and treatment of heart failure
     
46. TWEAK receptor
     
47. Cardiac muscle regeneration using mesenchymal stem cells
     
48. Noninvasive vascular therapy
     
49. High viscosity embolizing compositions
     
50. P49/STRAP is a novel protein involved in gene regulation and cell proliferation
     
51. Diagnosis and treatment of myocardial failure
     
52. Method of treating arrhythmias
     
53. High viscosity embolizing compositions comprising prepolymers
     
54. Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
     
55. Direct differentiation method for making cardiomyocytes from human embryonic stem cells
     
56. Alterations in the dystrophin gene associated with sporadic dilated cardiomyopathy
     
57. Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes
     
58. Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
     
59. Embolic materials
     
60. Methods for cardiac gene transfer
     
61. Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy
     
62. Migraine and vasodilation treatment
     
63. Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy
     
64. Aligned scaffolds for improved myocardial regeneration
     
65. Generation of therapeutic microfoam
     
66. Generating vascular smooth muscle cells in vitro from ES cells
     
67. Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)
     
68. Drug-eluting stent having collagen drug carrier chemically treated with genipin
     
69. Inhibitor of cardiac tachyarrhythmias
     
70. System and method for forming a cardiac muscle construct
     
71. Method of enhancing absorptions of transmucosal administration formulations
     
72. Growth factor therapy mobilization of stem cells into the peripheral blood
     
73. Apoptotic entities for use in treatment of endothelium dysfunction disorders
     
74. Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease
     
75. Elastin stabilization of connective tissue
     
76. Methods and compositions for correction of cardiac conduction disturbances
     
77. Antithrombin protein and DNA sequences from black fly
     
78. Preparation for the prevention and/or treatment of vascular disorders
     
79. Stem cells that transform to beating cardiomyocytes
     
80. Coatings containing polycationic peptides for cardiovascular therapy
     
81. Methods for treating congestive heart failure
     
82. Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
     
83. Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
     
84. Aspirin formulation for cardiovascular health
     
85. Method of treating left ventricular dysfunction
     
86. Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
     
87. Modulating transcription of genes in vascular cells
     
88. Beneficial effect of distiller's grain in cardiovascular disease
     
89. Use of EDG2 receptor in an animal model of heart failure
     
90. Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
     
91. Injection made from Ixeris Sonchifolia Hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof
     
92. Nicotine in therapeutic angiogenesis and vasculogenesis
     
93. Cilostazol preparation
     
94. Use of low-dose PDT to inhibit restenosis
     
95. Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha
     
96. Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange
     
97. Methods and compositions for the rapid and enduring relief of inadequate myocardial function
     
98. Breeding and milking cows for milk free of .beta.-casein A¹
     
99. Method for predicting cardiovascular events
     
100. Sequences characteristic of hypoxia-regulated gene transcription
      
101. Transplants for myocardial scars
     
 
102. Controlled absorption diltiazem pharmaceutical formulation
      
103. Methods for treating an artery or vein in a human subject
      
104. Human methionine synthase reductase: cloning, and methods for evaluating risk of, preventing, or treating neural tube defects, cardiovascular disease, cancer, and down's syndrome
      
105. Treatment of acute coronary syndrome with GLP-1
      
106. Delivery of beta-blockers through an inhalation route
      
107. Method of treating chronic cardiac disease
      
108. Composition and method for prevention and treatment of arrhythmias
      
109. Treatment of eclampsia and preeclampsia
      
110. Method and system for myocardial infarction repair
      
111. Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
      
112. Composition comprising ubiquinone
      
113. Methods for evaluating stroke or cardiac ischemia by nucleic acid detection
      
114. Anti-arrhythmic pharmaceutical composition and a process thereof
      
115. Gene therapy for cardiomyopathy
      
116. Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
      
117. Voltage-gated potassium channel and its use for development of therapeutics
      
118. Inhibition of vascular smooth muscle cell proliferation
      
119. Intrapericardial botulinum toxin treatment for bradycardia
      
120. KVLQT1—a long QT syndrome gene
      
121. Methods for suppressing early growth response—1protein (Egr-1) to reduce vascular injury in a subject
      
122. Thromboxane B2 metabolite methods for optimizing aspirin dosage
      
123. Methods and materials for evaluating cardiovascular conditions
      
124. Use of VEGF-C to prevent restenosis
      
125. Antithrombotic agents
      
126. Preventing and/or treating cardiovascular disease and/or associated heart failure
      
127. Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
      
128. Generation of therapeutic microfoam
      
129. Method for promoting neovascularization
      
130. Gene therapy for cerebrovascular disorders
      
131. Tissue factor for influencing blood vessel formation
      
132. Agents for improving lipid metabolism and reducing high blood pressure
      
133. Composition for the treatment and prevention of endothelial dysfunction
      
134. Transgenic mice comprising a constitutively-activated MEK5 and exhibiting cardiac hypertrophy and dilated cardiomyopathy
      
135. Method for regulation of microvascular tone
      
136. Vitamin formulation for cardiovascular health
      
137. Method of treating sick sinus syndrome with levosimendan
      
138. In vivo use of water absorbent polymers
      
139. Use of cortisol antagonists in the treatment of heart failure
      
140. Preventives or remedies for heart failure
      
141. Polymers for delivering nitric oxide in vivo
      
142. Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
      
143. Artery-and vein-specific proteins and uses therefor
      
144. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
      
145. Glycine betaine and its use
      
146. Reverse gene therapy
      
147. Method and compositions for inhibiting thrombin-induced coagulation
      
148. Mammalian dihydroouabain-like factor and therapeutic compositions
      
149. Cardiac-cell specific enhancer elements and uses thereof
      
150. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
      
151. Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin D receptor gene
      
152. Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor
      
153. Compositions and methods for the prevention and treatment of cardiovascular diseases
      
154. Vectors encoding HCN channels and MiRP1
      
155. Treatment of heart failure with growth hormone
      
156. Methods for treating cardiovascular diseases with botulinum toxin
      
157. Infrared thermography and methods of use
      
158. Methods for treating AVM's using radioactive compositions
      
159. Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
      
160. Methods and materials for protecting against myocardial cell damage related to coronary intervention by regional beta blocker therapy
      
161. Anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems
      
162. Method of modulating neovascularization
      
163. Method of treatment of cardiovascular injuries
      
164. Mutual prodrug of amlodipine and atorvastatin
      
165. Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
      
166. Use of relaxin treat diseases related to vasoconstriction
      
167. Therapeutic inhibitor of vascular smooth muscle cells
      
168. Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
      
169. Marker for inflammatory conditions
      
170. Methods for identifying cardiovascular agents
      
171. Treatment of microvascular angiopathies
      
172. Muscle cells and their use in cardiac repair
      
173. Transgenic mouse model for cardiac hypertrophy and methods of use thereof
      
174. Methods for measuring the metabolism of and screening for drugs in isolated hearts
      
175. Method of blocking blood vessel growth using tie-2 ligand 2
      
176. Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
      
177. Methods of treating vascular diseases characterized by nitric oxide insufficiency
      
178. Antiarrhythmic and tranquilizer composition and treatment
      
179. Nutritive composition for cardiovascular health
      
180. Intracellular inhibitors of Gq protein signaling
      
181. Method for in vivo regulation of cardiac muscle contractility
      
182. Methods and tests for producing and for inhibiting coronary artery vasospasms
      
183. Modulating transcription of genes in vascular cells
      
184. Therapeutic inhibitor of vascular smooth muscle cells
      
185. Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing RB2/p130
      
186. Agent for gene therapy of dilated cardiomyopathy
      
187. Angiogenic factor and use thereof in treating cardiovascular disease
      
188. Angiogenic factors and use thereof in treating cardiovascular disease
      
189. Method for treating heart disease and cardiovascular disease in diabetic and non-diabetic patients
      
190. Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof
      
191. Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
      
192. Aminotetralin derivatives for the therapy of cardiovascular diseases
      
193. Method of treating the syndrome of coronary heart disease risk factors in humans
      
194. Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
      
195. Multiple site delivery of adenoviral vector directly into muscle for the induction of angiogenesis
      
196. Method for reducing coronary artery reactivity
      
197. Cloning and characterization of bves, a novel gene expressed in heart and uses thereof
      
198. Compressed nitroglycerin tablet and its method of manufacture
      
199. Mechanical and pharmacologic therapies to treat cardiac arrest
      
200. Methods for the treatment of vascular disorders
      
201. Monohydrate lisinopril
      
202. Amorphous compound
      
203. Method of treating coronary artery disease by administering a recombinant FGF
      
204. Methods and compositions for treating Raynaud's Phenomenon and scleroderma
      
205. Angiogenically effective unit dose of FGF-2 and method of use
      
206. Specific pancreatic lipase inhibitors and their applications
      
207. Methods for treating vascular disorders
      
208. Zymogen activation system
      
209. Method of screening for a modulator of angiogenesis
      
210. Transmucosal formulations of levosimendan
     
     
211. Therapeutic inhibitor of vascular smooth muscle cells
     
     
212. Method of thrombolysis by local delivery of active plasmin
     
     
213. FGF Homologs
     
     
214. Method for reversing age-related changes in heart muscle cells
     
     
215. Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
      
     
216. Gene therapy in coronary angioplasty and bypass
      
     
217. Pharmaceutical formulations comprising vegetal material selected from trichilia 
      
218. Methods for embolizing blood vessels
      
     
219. Antibodies specific for vascular endothelial growth factor-B
      
     
220. Induction of angiogenesis in heart muscle by a DNA sequence encoding an angiogenic protein
      
     
221. Gene therapy for congestive heart failure
      
     
222. Heart homing peptides and methods of using same
      
     
223. Phospholipid complexes prepared from extracts of Vitis vinifera as anti-atherosclerotic agents
      
     
224. Anti-arteriosclerotic food
      
     
225. Systems and methods for local delivery of an agent
      
     
226. Pharmaceutical composition containing a combination of a statin and aspirin and method
      
     
227. Transgenic model and treatment for heart disease
      
     
228. Topical and oral delivery of arginine to cause beneficial effects
      
     
229. Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
      
     
230. Gene therapies for enhancing cardiac function
      
     
231. Herbal compositions and their use as agents for control of hypertension, hypercholesterolemia and hyperlipidemia
      
     
232. Systems and methods for topical treatment with nitric oxide
      
     
233. Unit dosage forms for treatment of vasoconstriction and related conditions

Treatment, Cataract

1. Use of extracts of Capraria biflora in the prevention and/or treatment of senile cataracts
    
2. Solution for removing cataracts via liquefracture
    
3. Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
    
4. Inhibitor of cataract formation
    
5. Lens epithelial cell derived growth factor
    
6. Use of a vital dye for facilitating surgical procedures for cataract extraction
    
7. Methods and compositions for treating cataracts using substances derived from yeast or saltbush
    
8. Composition and method for the prevention and treatment of oxidative damage in ocular tissues
   
   
9. Method for preventing or controlling cataract

Treatment, Celiac Disease

1. Materials and methods for the treatment of celiac disease
    
2. Drug therapy for Celiac Sprue
    
3. Immunological assay for detection of antibodies in celiac disease
    
4. Method for treating celiac disease

Treatment, Cell Hyperproliferation Related Disorders

1. Screening methods for compounds useful in the regulation of cell proliferation
    
2. Enzyme combinations for destroying proliferative cells
    
3. Antiproliferative Sgk reagents and methods
    
4. Method of screening for a modulator of angiogenesis

Treatment, Cerebral Edemas

1. Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas

Treatment, Cerebral Palsy

1. Botulinum toxin neurotoxic component for treating juvenile cerebral palsy
    
2. Methods and compositions for the treatment of cerebral palsy
    
3. Method and compositions for the treatment of cerebral palsy

Treatment, Cervical Related Disorders/Cancer

1. Nicotinamide N-methyltransferase as a marker for colorectal cancer
    
2. Genetic immunization against cervical carcinoma
    
3. Use of N-acetyl-D-glucosamine in the manufacture of a medicament for treating cervical erosion
    
4. Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2

Treatment, Chagas' Disease

1. Prophylactic and therapeutic immunization against protozoan infection and disease
    
2. Antigens and immunoassays for diagnosing Chagas' disease
    
3.  Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease

Treatment, Chicken Pox/Shingles

1. Method and composition for the treatment of shingles and related afflictions
    
2. VZV gene, mutant VZV and immunogenic compositions

Treatment, Chlamydia Infection

1. Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
    
2. Methods and compositions for immunizing against Chlamydia infection
    
3. Non-antibiotic intervention of chlamydial infection
    
4. Chlamydia PMP proteins, gene sequences and uses thereof
    
5. Cytotoxic T-cell epitopes from Chlamydia
    
6. Chlamydia antigens and protein vaccine
    
7. Chlamydia oligosaccharides
    
8. Immunisation against Chlamydia trachomatis
    
9. Compositions, methods and kits for diagnosis and treatment of Chlamydia pneumoniae infections of the skin and those associated with cutaneous T-cell lymphoma
    
10. DNA immunization against Chlamydia infection
     
11. Medicament for the treatment of chlamydial infection
     
12. Chlamydia antigens and corresponding DNA fragments and uses thereof
     
13. DNA immunization against Chlamydia infection
     
14. Mouse disease model for evaluation of prophylactic and therapeutic treatments of Chlamydia
     
15. One step immunization procedure for inducing a Chlamydia specific immune response
     
16. Chlamydia antigens and corresponding DNA fragments and uses thereof
     
17. Diagnosis and management of infection caused by Chlamydia
     
18. Immunogenic compositions for protection against chlamydial infection
     
19. DNA immunization against chlamydia infection
     
20. Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
     
21. Two-step immunization procedure against Chlamydia infection
     
22. Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis
     
23. Recombinant Chlamydia trachomatis PGP3 antigen
     
24. DNA immunization against chlamydia infection
     
25. Diagnosis and management of infection caused by chlamydia
     
26. Compounds and methods for treatment and diagnosis of chlamydial infection
     
27. Chlamydia antigens and corresponding DNA fragments and uses thereof (* Large Document, Long Loading Time)
    
    
28. DNA immunization against chlaymdia infection
    
    
29. DNA immunization against chlamydia infection

Treatment, Cholesterol/Triglycerides Related Disorders

1. Cholesterol absorption inhibitor
    
2. Antibody that specifically binds hyaluronan synthase
    
3. Nanoparticulate fibrate formulations
    
4. Combination therapy for treating hypercholesterolemia
    
5. Screening and selection methods for statin drug combinations
    
6. Method for detecting intracellular cholesterol
    
7. Nanoparticulate fibrate formulations
    
8. Lactobacillus casei Bd-II stain and used to reduce blood cholesterol
    
9. Therapeutic uses of Dunaliella powder
    
10. Cholesterol reducing chewing gum composition and method of making the same
     
11. Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
     
12. Direct assay of cholesterol in skin samples removed by tape stripping
     
13. NPC1L1 (NPC3) and methods of use thereof
     
14. Method for increasing HDL cholesterol level
     
15. Cell culture system for determining the cholesterol efflux potential for serum
     
16. Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
     
17. Chewable compositions containing a gel-forming extract of psyllium
     
18. Blood lipid ameliorant composition
     
19. Methods for modulation of cholesterol transport
     
20. Cholesterol lowering supplement
     
21. Compositions for improving lipid content in the blood
     
22. Method for quantifying cholesterol in high density lipoprotein
     
23. Methods and compositions for the treatment of defects in lipoprotein metabolism
     
24. Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
     
25. Lipid hydrolysis therapy for atherosclerosis and related diseases
     
26. Monoclonal antibodies to the human LDL receptor, their production and use
     
27. Compositions and methods of modulating cholesterol metabolism
     
28. Charged lipid compositions and methods for their use
     
29. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
     
30. Method and composition for regulation of blood cholesterol
     
31. Antisense modulation of microsomal triglyceride transfer protein expression
     
32. DNA encoding human apoB48R: a monocyte-macrophage apolipoprotein B48 receptor gene and protein
     
33. Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
     
34. Compositions and methods for modulating serum cholesterol
     
35. Antilipemic formulation
     
36. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
     
37. Composition and method for treatment of hypertriglyceridemia
     
38. Dietary supplements for treating hyperlipemia
     
39. Method for concentrating beta-glucan film
     
40. Hypertension-treatment and cholesterol-depressant composition comprising extract from mixture of Panax notoginseng and Salvia miltiorrhiza and method of preparing the same
     
41. Cholesterol lowering beverage
     
42. Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin
     
43. Compositions and methods for reducing oxysterols in blood
     
44. Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin
     
45. Combinations of psyllium and chitosan for synergistic adsorption of triglyceride
     
46. Methods and compositions for reducing cholesterol levels using a proanthocyanidin and niacin-bound chromium complex
     
47. Cholesterol lowering composition
     
48. Mixture of primary fatty acids obtained from sugar cane wax
     
49. Combination therapy for treating hypercholesterolemia
    
    
50. Rain forest plant extract with cellular cholesterol lowering properties
    
    
51. Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
    
    
52. Method of decreasing cholesterol and triglycerides levels with a composition containing fish oil, garlic, rutin, and capsaicin
     
    
53. Method for concentrating .beta.-glucan
     
    
54. Medicinal compositions with cholesterol-lowering effect
     
    
55. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants

Treatment, Chronic Fatigue Syndrome

1. Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
    
2. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
    
3. Method for removing the transforming growth factor-.beta. by adsorption
    
4. Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders
    
5. Use of 5HT3-receptor antagonists for the treatment of chronic fatigue syndrome
    
6. Cellular immunotherapy treatment of patients afflicted with chronic fatigue syndrome

Treatment, Circadian Rhythm Disorders

1. cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use
    
2. Compositions and methods for regulating circadian rhythms
    
3. Compositions normalizing circadian rhythm
    
4. Methods for treating circadian rhythm phase disturbances
    
5. Methods for treating circadian rhythm disorders

Treatment, Colic

1. Composition and method useful for treating colic

Treatment, Colorectal Cancer

1. Chimeric, human and humanized anti-CSAp monoclonal antibodies
    
2. Antibody with specificity for colon cancer
    
3. Antibodies against cancer
    
4. Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
    
5. Colorectal neoplasia prophylaxis
    
6. Biological compositions and methods for treatment of colorectal cancer
    
7. Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer
    
8. Colorectal neoplasia prophylaxis
    
9. Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
    
10. Methods of inhibiting metastases
     
11. Method for the prevention of colonic adenomas
     
12. Metastatic breast and colon cancer regulated genes
     
13. Method for inhibiting brain tumor or colon carcinoma
     
14. Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
     
15. A33 antigen specific immunoglobulin products and uses thereof 
    
    
16. Method for colorectal cancer prognosis and treatment selection
     
    
17. Composition and method for reducing the risk of carcinogenesis

Treatment, Common Colds

1. Compositions for treatment of common cold
    
2. Method and composition for delivering zinc to the nasal membrane
    
3. Method and composition for delivering zinc to the nasal membrane
    
4. Gargle method to reduce the duration of common cold symptoms
    
5. Compositions for common colds

Treatment, Congenital Disorders

1. Methods for treating AVM's using radioactive compositions

Treatment, Congestive Heart Failure

1. Method for the treatment of heart failure
    
2. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
    
3. Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange
    
4. Method of treating chronic cardiac disease
    
5. Mammalian dihydroouabain-like factor and therapeutic compositions
    
6. Treatment of heart failure with growth hormone
    
7. Methods for treating congestive heart failure
    
8. Method for in vivo regulation of cardiac muscle contractility
    
9. Treatment of congestive heart failure
    
10. High throughput sarcomeric assay

Treatment, Connective Tissue Related Disorders

1. Method of treatment of connective tissue disorders by administration of streptolysin O
    
2. .alpha.2-macroglobulin receptor as a receptor for CTGF

Treatment, Constipation

1. Methods of treating dyschezia
    
2. Synthetic bulk laxative
    
3. Unfermented gel fraction from psyllium seed husks
    
4. Composition for treatment of constipation and irritable bowel syndrome
    
5. Use of 5HT3 antagonists for promoting intestinal lavage
    
6. Therapy for constipation

Treatment, Contraception

1. Multi-phase contraceptive preparation based on a natural estrogen
    
2. Contraceptives based on SP22 and SP22 antibodies
    
3. Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation
    
4. Non-hormonal vaginal contraceptive
    
5. Nasal spray steroid formulation and method
    
6. Male contraceptive formulation comprising norethisterone
    
7. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
    
8. Combination progestin oral contraceptive regimen
    
9. Methods for identifying contraceptive compounds
    
10. Pharmaceutical composition for use as a contraceptive
     
11. D-mannose contraceptives
     
12. Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
     
13. Chewable oral contraceptive
     
14. Progestogen-antiprogestogen regimens
     
15. Transdermal therapeutic system containing estradiol
     
16. Soluble contraceptive liquid formulation
     
17. WNT signalling in reproductive organs
     
18. Composition and method for contraception and treatment of tumors of the mammary glands
     
19. Neuronal uses of BMP-11
     
    
20. Process for the preparation of a spermicidal agent
     
    
21. Pharmaceutical combined preparation, kit and method for hormonal contraception
     
    
22. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
     
    
23. Corn extract contraceptive
     
    
24. Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception
     
    
25. Combination progestin oral contraceptive regimen
     
    
26. Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
     
    
27. Contraceptive method employing buccal delivery of steroidal active agents 
     
    
28. Buccal drug delivery system for use in male contraception

Treatment, Convulsion/Seizure

1. Treatment of convulsive states
    
2. Transnasal anticonvulsive compositions and modulated process
    
3. Transgenic mice exhibiting increased susceptibility to seizures
    
4. Compositions and methods for treating or preventing convulsions or seizures

Treatment, Cosmetic, Surgery/Deformity

1. Method and composition for restoration of age related tissue loss in the face or selected areas of the body
    
2. Biodegradable injectable implants containing glycolic acid
    
3. Methods of using Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)
    
4. Methods for treating a buttock deformity
    
5. Diphasic injection composition containing dispersed and continuous phases useful for reparative and plastic surgery
    
6. Cosmetic use of botulinum toxin for treatment of downturned mouth

Treatment, Cough Suppression/Related Disorders

1. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
    
2. Mucosal DTPa vaccines
    
3. Intranasal codeine for the rapid suppression of cough and rapid relief of pain

Treatment, Crohn's Disease/Ulcerative Colitis

1. Method for monitoring the efficacy of a Mycobacterium avium subspecies paratuberculosis therapy
    
2. Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies
    
3. Methods of inhibiting TNF-.alpha. in patients with Crohn's disease
    
4. Use of lipid conjugates in the treatment of diseases
    
5. Method for treating crohn's disease
    
6. Probiotic compositions for the treatment of inflammatory bowel disease
    
7. Method of treating ulcerative colitis and Crohn's disease using IL-17 receptor proteins
    
8. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
    
9. Method and test kit for measuring immunoglobulins reactive with amylase as indication of crohn's disease
    
10. Use of parasitic biological agents for prevention and control of autoimmune diseases
     
11. Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
     
12. Preventives/remedies for inflammatory intestinal disease
     
13. Methods and compositions for treating inflammatory bowel disease
     
14. Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
     
15. Use of panaverium bromide for preventing cell proliferation and diseases caused thereby in the liver and digestive tract
     
16. Method for the treatment of inflammatory bowel diseases

Treatment, Cystic Fibrosis

1. Methods for diagnosing cystic fibrosis
    
2. Gene therapy by small fragment homologous replacement
    
3. Product and process for liquefaction of mucus or sputum
    
4. Cystic fibrosis gene
    
5. Methods and compositions for increasing the infectivity of gene transfer vectors
    
6. Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)
    
7. Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
    
8. Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
    
9. In Utero treatment of CFTR-related deficiencies